FDA Safety Communication for Ocaliva
FDA issues new communication about risk of liver injury with Ocaliva (obeticholic acid).
FDA Okays Benzodiazepines and Medication-Assisted Opioid Addiction Treatment
A new communication says benzodiazepines can be used with buprenorphine or methadone, if carefully managed.
Specialty Drug Prices Help Increase Insurance Costs
New data show that health benefit costs in 2018 will rise by their highest since 2011.
FDA Considers Compounding Pharmacy Regulations
Gottlieb says that changes may be coming, but remains firm on current regulations.
Neratinib for Early Stage Breast Cancer
Neratinib (Nerlynx) is an extended adjuvant treatment for patients with early stage HER2 positive breast cancer who are receiving trastuzumab therapy.
Limits on Opioid Prescriptions Gain Popularity
Opioid limits are gaining popularity, but do they actually work?
Express Scripts’ New Formulary Favors Biosimilars, Cuts Opioids
Check out the latest changes to the Express Scripts formulary
FDA Sends Warning Letter to EpiPen Manufacturer
EpiPen manufacturer is accused of lax investigation into problems.
FDA Recommends Separate Dosing for Kayexalate
Sodium polystyrene sulfonate interferes with many oral drugs and should be dosed separately.
FDA Warning on Keytruda
After trials halted, FDA issues warning on off-label use of the drug.
Leukemia Drug Approved-For the Second Time
After Mylotarg was taken voluntarily taken off the market, the FDA is giving it a second chance.
New York City Bans Pharmacy Tobacco Sales
The city's decision is the latest move against tobacco in pharmacies.
Two OTC Cold Medications Recalled Due to Bacterial Contamination
Mid Valley Pharmaceutical recalls two drugs.
Should the FDA Drop High-Dose Opioids?
A petition sent by multiple groups says yes.
FDA Approves First Gene Therapy
Why the agency says the approval of Novartis’ new therapy is historic.
FDA Cracks Down on Regenerative and Stem Cell Therapies
New therapies hold great promise-and great danger.
Ninjacof Recall, Tied to Previous PharmaTech Recalls
The recall is just the latest in a bacterial contamination scare.
Online Pharmacies: A Safety Concern?
Why the NABP says Canada isn't a safe alternative.
New Bill Could Force E-prescribing
Legislators say it will help ease the problem, but the NCPA says it’s just one part of the solution.
Express Scripts Limits Opioid Prescriptions
The PBM giant is cutting down on the number of opioids new patients can buy.
Mylan Finalizes $465 Million EpiPen Settlement
The settlement is the end of a long legal battle.
Biosimilars Market Taking Off in the United States
After many years of speculation, a number of biosimilar drugs are hitting the U.S. market.
Inconsistent Labeling of Sulfites Could Cause Harm
A tricky labeling system could be affecting your patients.
Amneal Recalls 13 Lots of Lorazepam Oral
The provided droppers may have been mislabeled.
Residency Programs: Not Enough to Go Around
Why are residency programs becoming harder to find?
Increased Psychiatric Med Use Means Expanded Pharmacist Role
Patients need more help managing complicated meds than ever-and pharmacists are there to help.
Kmart Opens First Telepharmacy with Plans for More
The first test store in Des Plaines could be just the start.
Merger Failure: New Industry Direction?
The failed Rite Aid/Walgreens merger might mean the end of business as usual.
Temperature Control Is Key to Vaccine Storage
Is your pharmacy's refrigerator maintaining the right temperature?
Pravastatin Bottles Recalled: Actual Content Is Bupropion
International Laboratories recalling one lot of bottles labeled 40-mg pravastatin.